Peter Heerma

All filings by Peter Heerma on record concern Travere Therapeutics, Inc. Between 15 September 2026 and 17 September 2026, the trades on record add up to 3 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 17 September 2026, the filings show a transaction worth €459k in Travere Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.